Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCC
Background: Cell division cycle 6 (CDC6) is a member of the AAA+ ATPase family and has chaperone-like activity. Many studies have shown that CDC6 plays an important role in cancer development and progression. Methods: Explored CDC6 mRNA and protein expression in normal human tissues and tumors using...
Saved in:
Main Authors: | Chenxuan Li, En-di Zhang, Rui Yu, Bo Yuan, Yunxin Yang, Zhong Zeng, Hanfei Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325000452 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CDC20‐Mediated Selective Autophagy Degradation of PBRM1 Affects Immunotherapy for Renal Cell Carcinoma
by: Yizeng Fan, et al.
Published: (2025-02-01) -
Underlying and contributing causes of mortality from CDC WONDER—Insights for researchers
by: Abdul Mannan Khan Minhas, et al.
Published: (2025-02-01) -
Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
by: Nie Zhang, et al.
Published: (2025-01-01) -
AIFM1 is a prognostic biomarker for uterine carcinosarcoma and is associated with immune cell infiltration
by: Lijuan Wang, et al.
Published: (2025-02-01) -
Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
by: Zhaoda Deng, et al.
Published: (2025-01-01)